259 related articles for article (PubMed ID: 9822542)
1. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
Yoo HW; Suh ME; Park SW
J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
[TBL] [Abstract][Full Text] [Related]
2. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo [4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-[1,4]oxazino[3',4':2,3]imidazo[4,5-g]quinoline-5,12-dio ne derivatives.
Suh ME; Kang MJ; Yoo HW; Park SY; Lee CO
Bioorg Med Chem; 2000 Aug; 8(8):2079-83. PubMed ID: 11003153
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of quinoxaline derivatives on human cancer cell lines.
Yoo HW; Lee YS; Suh ME; Kim DJ; Park SW
Arch Pharm (Weinheim); 1998 Oct; 331(10):331-3. PubMed ID: 9844581
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
6. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
Moorthy NS; Karthikeyan C; Trivedi P
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
11. Novel imidazo[1,2-a]naphthyridinic systems (part 1): synthesis, antiproliferative and DNA-intercalating activities.
Andaloussi M; Moreau E; Masurier N; Lacroix J; Gaudreault RC; Chezal JM; El Laghdach A; Canitrot D; Debiton E; Teulade JC; Chavignon O
Eur J Med Chem; 2008 Nov; 43(11):2505-17. PubMed ID: 18403058
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds.
Kuo SC; Ibuka T; Huang LJ; Lien JC; Yean SR; Huang SC; Lednicer D; Morris-Natschke S; Lee KH
J Med Chem; 1996 Mar; 39(7):1447-51. PubMed ID: 8691475
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxicity of 1-substituted 2-methyl-1H-imidazo[4,5-g]phthalazine-4,9-dione derivatives.
Sung Kim J; Lee HJ; Suh ME; Choo HY; Lee SK; Park HJ; Kim C; Park SW; Lee CO
Bioorg Med Chem; 2004 Jul; 12(13):3683-6. PubMed ID: 15186853
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity evaluation of 6,11-dihydro-pyridazo- and 6,11-dihydro-pyrido[2,3-b]phenazine-6,11-diones.
Lee HJ; Kim JS; Park SY; Suh ME; Kim HJ; Seo EK; Lee CO
Bioorg Med Chem; 2004 Apr; 12(7):1623-8. PubMed ID: 15028255
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
[TBL] [Abstract][Full Text] [Related]
17. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
18. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
[TBL] [Abstract][Full Text] [Related]
19. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
20. Benzofused tricycles based on 2-quinoxalinol.
Liu G; Li L; Kou B; Zhang S; Zhang L; Yuan Y; Ma T; Shang Y; Li Y
J Comb Chem; 2007; 9(1):70-8. PubMed ID: 17206834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
